The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.

Shea, M J; Driscoll, E M; Romson, J L; Pitt, B; Lucchesi, B R

Shea, M J; Driscoll, E M; Romson, J L; Pitt, B; Lucchesi, B R.

Am Heart J ; 107(4): 629-37, 1984 Apr.

Article in En | MEDLINE | ID: mdl-6702555

Subject(s)

Coronary Disease/drug therapy; Fibrinolytic Agents/therapeutic use; Pyrazoles/therapeutic use; Pyrazolones; Adenosine Diphosphate/pharmacology; Animals; Blood Pressure; Collagen/pharmacology; Coronary Circulation; Coronary Disease/blood; Coronary Disease/physiopathology; Dogs; Electrocardiography; Male; Platelet Aggregation/drug effects

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Pyrazoles / Coronary Disease / Pyrazolones / Fibrinolytic Agents Limits: Animals Language: En Year: 1984 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Pyrazoles / Coronary Disease / Pyrazolones / Fibrinolytic Agents Limits: Animals Language: En Year: 1984 Type: Article